ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0430505868034761 0.18272499
NSC 733504 Everolimus 0.0430505868034761 0.062107342
NSC 737231 Null 0.0430505868034761 0.10935098
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0430505868034761 0.24898813
NSC 740 Methotrexate 0.0430505868034761 0.45126997
NSC 744063 Null 0.0430505868034761 0.22998512
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0430505868034761 0.13130311
NSC 758423 Amsacrine (USAN) 0.0430505868034761 0.74031329
NSC 87868 2-Phenylethyl isothiocyanate 0.0430505868034761 0.22352402
NSC 109834 Null 0.0430505868034764 0.29960476
Total:99  Current:89    [First] [Prev] [Next] [Last]